Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
SAGE Open Medicine|December 22, 2018
Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover studySilvia Bonanno, Maria Barbara Pasanisi, Rita Frangiamore, et al.
Annals of Neurology|June 3, 2010
Epstein-Barr virus persistence and reactivation in myasthenia gravis thymusPaola Cavalcante, Barbara Serafini, Barbara Rosicarelli, et al.
Autoimmune Diseases|October 1, 2011
Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesisPaola Cavalcante, Lorenzo Maggi, Lara Colleoni, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Myasthenia gravis (MG): epidemiological data and prognostic factorsRenato Mantegazza, Fulvio Baggi, Carlo Antozzi, et al.
Clinical Immunology (Orlando, Fla.)|October 11, 2016
Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapiesChiara Cordiglieri, Fulvio Baggi, Pia Bernasconi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2026
Disease changes and cost analysis of myasthenia gravis: a 10 years retrospective study from a reference center in ItalyRenato Mantegazza, Carlo Antozzi, Fulvio Baggi, et al.
Neurology|December 21, 2012
Complete stable remission and autoantibody specificity in myasthenia gravisFulvio Baggi, Francesca Andreetta, Lorenzo Maggi, et al.
Plos One|January 4, 2013
An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastomaSara Nava, Marta Dossena, Simona Pogliani, et al.
European Neurology|September 30, 2009
Immunological reactivity against neuronal and non-neuronal antigens in sporadic adult-onset cerebellar ataxiaRoberto Fancellu, Davide Pareyson, Elena Corsini, et al.
Orphanet Journal of Rare Diseases|August 15, 2013
SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoproteinLorenzo Nanetti, Simona Cavalieri, Viviana Pensato, et al.
Pageof 9